MDGL
Price
$298.87
Change
-$1.28 (-0.43%)
Updated
Jul 3 closing price
Capitalization
6.64B
32 days until earnings call
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
825.75K
34 days until earnings call
Interact to see
Advertisement

MDGL vs SQZB

Header iconMDGL vs SQZB Comparison
Open Charts MDGL vs SQZBBanner chart's image
Madrigal Pharmaceuticals
Price$298.87
Change-$1.28 (-0.43%)
Volume$108.67K
Capitalization6.64B
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$5K
Capitalization825.75K
MDGL vs SQZB Comparison Chart in %
Loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDGL vs. SQZB commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a StrongBuy and SQZB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (MDGL: $298.87 vs. SQZB: $0.03)
Brand notoriety: MDGL and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 34% vs. SQZB: 19%
Market capitalization -- MDGL: $6.64B vs. SQZB: $825.75K
MDGL [@Biotechnology] is valued at $6.64B. SQZB’s [@Biotechnology] market capitalization is $825.75K. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 0 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 0 green, 5 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than SQZB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 5 TA indicator(s) are bullish while SQZB’s TA Score has 2 bullish TA indicator(s).

  • MDGL’s TA Score: 5 bullish, 4 bearish.
  • SQZB’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than SQZB.

Price Growth

MDGL (@Biotechnology) experienced а -0.21% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MDGL is expected to report earnings on Aug 06, 2025.

SQZB is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.64B) has a higher market cap than SQZB($826K). MDGL YTD gains are higher at: -3.144 vs. SQZB (-6.667).
MDGLSQZBMDGL / SQZB
Capitalization6.64B826K803,390%
EBITDA-376.15MN/A-
Gain YTD-3.144-6.66747%
P/E RatioN/AN/A-
Revenue317MN/A-
Total Cash843MN/A-
Total Debt120MN/A-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGLSQZB
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBT12.910.19
+1.49%
Permian Basin Royalty Trust
BIRD10.610.13
+1.29%
Allbirds Inc
SCKT1.140.01
+0.88%
Socket Mobile
SPB56.580.14
+0.25%
Spectrum Brands Holdings
ALB67.21-0.78
-1.15%
Albemarle Corp

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-0.43%
KANT - MDGL
62%
Loosely correlated
N/A
ALXO - MDGL
56%
Loosely correlated
+3.39%
CGEM - MDGL
50%
Loosely correlated
+0.64%
NAGE - MDGL
45%
Loosely correlated
+1.03%
IPHA - MDGL
44%
Loosely correlated
N/A
More

SQZB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SQZB has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SQZB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
MDGL - SQZB
33%
Loosely correlated
-0.43%
ARRY - SQZB
33%
Loosely correlated
+11.93%
AXON - SQZB
33%
Poorly correlated
+2.70%
MIST - SQZB
31%
Poorly correlated
+1.04%
LYRA - SQZB
29%
Poorly correlated
-3.33%
More